Standard Biotools (LAB) Construction in Progress (2011 - 2026)
Standard Biotools (LAB) reported Construction in Progress of $823000.0 for Q1 2026, down 88.23% year-over-year from $7.0 million in Q1 2025, and down 8.56% on a QoQ basis from $900000.0 in Q4 2025.
Standard Biotools (LAB) has 16 years of Construction in Progress data on file, last reported at $823000.0 in Q1 2026.
- Quarterly Construction in Progress fell 88.23% year-over-year to $823000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $823000.0 (down 88.23% YoY) and the FY2025 annual result came in at $900000.0, down 85.07% from the prior year.
- Construction in Progress retreated to $823000.0 in Q1 2026 per LAB's latest filing, from $900000.0 in the prior quarter.
- Across five years, Construction in Progress topped out at $7.0 million in Q1 2025 and bottomed at $375000.0 in Q3 2025.
- The 5-year median for Construction in Progress is $2.1 million (2022), against an average of $2.8 million.
- The widest annual swing landed in 2024, when Construction in Progress jumped 205.84%; it then tumbled 93.97% in 2025.
- Tracing LAB's Construction in Progress over 5 years: stood at $1.6 million in 2022, then jumped by 44.79% to $2.3 million in 2023, then soared by 158.27% to $6.0 million in 2024, then plunged by 85.07% to $900000.0 in 2025, then retreated by 8.56% to $823000.0 in 2026.
- Per Business Quant, the three latest LAB Construction in Progress figures stand at $823000.0 (Q1 2026), $900000.0 (Q4 2025), and $375000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.12 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 509.50 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn | 823,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 823,000.00 |
| Dec 31, 2025 | 900,000.00 |
| Sep 30, 2025 | 375,000.00 |
| Jun 30, 2025 | 473,000.00 |
| Mar 31, 2025 | 6.99 Mn |
| Dec 31, 2024 | 6.03 Mn |
| Sep 30, 2024 | 6.22 Mn |
| Jun 30, 2024 | 5.35 Mn |
| Mar 31, 2024 | 4.81 Mn |
| Dec 31, 2023 | 2.33 Mn |
| Sep 30, 2023 | 3.05 Mn |
| Jun 30, 2023 | 2.29 Mn |
| Mar 31, 2023 | 1.57 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 2.08 Mn |
| Mar 31, 2022 | 1.66 Mn |
| Dec 31, 2021 | 4.55 Mn |
| Sep 30, 2021 | 22.00 Mn |
| Jun 30, 2021 | 20.52 Mn |
| Mar 31, 2021 | 16.64 Mn |
| Dec 31, 2020 | 9.98 Mn |
| Sep 30, 2020 | 113,000.00 |
| Jun 30, 2020 | 108,000.00 |
| Mar 31, 2020 | 262,000.00 |
| Dec 31, 2019 | 76,000.00 |
| Sep 30, 2019 | 7,000.00 |
| Jun 30, 2019 | 94,000.00 |
| Mar 31, 2019 | 20,000.00 |
| Dec 31, 2018 | 20,000.00 |
| Sep 30, 2018 | 8,000.00 |
| Jun 30, 2018 | 47,000.00 |
| Mar 31, 2018 | 49,000.00 |
| Dec 31, 2017 | 8,000.00 |
| Sep 30, 2017 | 32,000.00 |
| Jun 30, 2017 | 115,000.00 |
| Mar 31, 2017 | 654,000.00 |
| Dec 31, 2016 | 611,000.00 |
| Sep 30, 2016 | 596,000.00 |
| Jun 30, 2016 | 930,000.00 |
| Mar 31, 2016 | 449,000.00 |
| Dec 31, 2015 | 586,000.00 |
| Sep 30, 2015 | 486,000.00 |
| Jun 30, 2015 | 812,000.00 |
| Mar 31, 2015 | 1.11 Mn |
| Dec 31, 2014 | 1.96 Mn |
| Sep 30, 2014 | 2.93 Mn |
| Jun 30, 2014 | 5.39 Mn |
| Dec 31, 2013 | 2.28 Mn |
| Dec 31, 2012 | 1.14 Mn |
| Dec 31, 2011 | 959,000.00 |